BioRestorative Therapies extends VP R&D Silva's employment; $575K salary unchanged, term to June 2029

BioRestorative Therapies, Inc.

New employment agreement for VP R&D Francisco Silva, effective June 10, 2026, with term through June 10, 2029.
Salary remains at $575,000 per year; eligible for annual discretionary bonus up to 50% of salary.
On termination without cause or resignation for good reason, severance equals 1.5x (salary + max bonus), plus COBRA paid for 1.5 years, and full vesting of equity awards.
Non-compete and non-solicitation covenants apply for 1 year post-termination within US in stem-cell based therapies and biocosmeceuticals.
Agreement includes assignment of all developments and inventions related to company's business as work made for hire.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.